Cell and Gene Therapy Catapult
Overview
Cell and Gene Therapy Catapult is an independent, non-profit innovation and technology organization established to advance the growth of the UK's cell and gene therapy industry.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Stratosvir | Apr 2026 | VC Round | Co-investor |
| Lir Therapeutics | - | Seed | Co-investor |
| Plurify | Jan 2024 | Seed | Co-investor |
| Korecyte Bio | May 2026 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cell and Gene Therapy Catapult based?
Cell and Gene Therapy Catapult is headquartered in London, United Kingdom.
When was Cell and Gene Therapy Catapult founded?
Cell and Gene Therapy Catapult was founded in 2012.
How many portfolio companies does Cell and Gene Therapy Catapult have?
Cell and Gene Therapy Catapult has 5 portfolio companies in Caplight's dataset.
What are some companies in Cell and Gene Therapy Catapult's portfolio?
Portfolio companies visible on Caplight include Stratosvir, Lir Therapeutics, Plurify, Korecyte Bio.
What was Cell and Gene Therapy Catapult's most recent investment shown here?
Cell and Gene Therapy Catapult's most recent investment in this portfolio sample was in Korecyte Bio in 2026.
What sectors does Cell and Gene Therapy Catapult focus on?
Cell and Gene Therapy Catapult focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does Cell and Gene Therapy Catapult focus on?
Stage focus information for Cell and Gene Therapy Catapult is not publicly available.